On the podcast this week we have conversations with Change Foods founder and CEO, David Bucca; Mark Robert, technical director, food & beverage solutions, Tate & Lyle; and Peter Lamb, COO of Adventa Bioscience.
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
A new report by WHO, UNICEF, and the International Baby Food Action Network (IBFAN) says despite efforts to stop the promotion of breast-milk substitutes, countries are still falling short in protecting parents from misleading information.
Kiwi scientists have published nationally representative research on the breastmilk composition of breastfeeding mothers in the country, which could aid the development of supplements or programmes to support the health of breastfeeding mothers and their...
Human milk oligosaccharides (HMOs) have extensive potential to offer a range of health benefits in products beyond infant formula, DuPont's global business director for HMOs, Steen Lyck, said at Vitafoods Asia on Tuesday.
Supplements containing specific human milk oligosaccharides from breast milk may selectively modify the gut microbiome in healthy adults, says a new study that also supports the safety and tolerability of the ingredients.